Amgen's dividend looks great, and the stock is reasonably valued. Even so, there remain strong reasons to invest in Amgen and ...

First there were Victoza and Saxenda, then Ozempic seized the spotlight - followed by Wegovy and Mounjaro. And ever-better ...

A weekly selection of opinions and analyses from the Arab media around the world. From Gaza Tunnels to New York ...

The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg ...

Novo Nordisk's and Eli Lilly's blockbuster weight-loss drugs should be the first medicines doctors reach for to treat obesity ...

As semaglutide hits pharmacy shelves for $499, doctors weigh the pros and cons of brand-name vs. compounded meds.

GLP-1 injections use needles and require refrigeration. Pills that work in a similar way could be a cheaper, simpler solution.

At 293 pounds, Stormie Fish couldn’t carry her toddler from the parking lot at Northmoreland Park in Allegheny Township into ...

New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and ...

What's the most attractive Big Pharma stock right now for investors? Seeking Alpha analysts weigh in. Read more here.

Novo took the active ingredient of Ozempic, semaglutide, and rebranded it as Wegovy to be used specifically for weight loss.

New research findings show a significant increase in the use of weight loss drugs among patients undergoing metabolic and bariatric surgery, signaling an evolution in the management of obesity and ...